|
| |
Posology and method of administration
Depending on the degree of severity of the hyperthyroidism the initial
dose is 20 - 40 mg thiamazole/day for a period of 3 - 6 weeks. After
this the dose can be reduced to a maintenance dose of 20 to 10 -
5 mg thiamazole/day. From this point on concomitant therapy with thyroid
hormone is recommended.
Alternative:
Monotherapy with 2.5 - 10 mg thiamazole/day.
In pregnancy:
Thiamazole should be given in as low a dose as possible, e.g. 2.5 -
10 mg thiamazole/day without concomitant therapy with thyroid hormones.
Preoperative administration:
20 - 40 mg thiamazole/day until the hyperthyroidism has been eliminated.
To shorten the period of time before surgery is performed Thyrozol 5 can
be given in combination with a beta-blocker and/or iodine preparation.
Radioiodine therapy:
Before radioiodine therapy: 20 - 40 mg thiamazole/day.
After radioiodine therapy: 20 - 10 to 5 mg thiamazole/day depending
on the symptoms up to onset of the radioiodine effect.
Antithyroid maintenance therapy:
2.5 - 10 mg thiamazole/day with or without the addition of a low levothyroxine
dose.
Prophylactic treatment in latent hyperthyroidism before exposure
to iodine:
20 - 40 mg thiamazole/day in combination with levothyroxine.
Ingestion: the tablets should be swallowed whole after meals, preferably
with a little liquid.
The daily dose can be divided up into 2 - 3 single doses or it can be
administered in one dose. Therapy is usually given over a period of 6 months
to 2 years.
In preoperative preparation Thyrozol is given up to the time of the
operation.
When used in preparation for radioiodine therapy Thyrozol is given up
to about 7 days before the administration of radioiodine and is continued
10 days after the therapy for a further period of 2 - 4 months as intermediate
therapy up to the onset of the effect of the radioiodine therapy.
In prophylactic treatment prior to exposure to iodine the duration depends
on the retention time of the iodine-containing substance in the organism.
Contraindications
Known hypersensitivity to thiamazole or thionamides. Previous bone marrow
damage after carbimazole or thiamazole is an absolute contra-indication.
Earlier allergic skin reactions to thionamides constitute a relative
contra-indication. Large goiters which constrict the trachea should only
be treated with thiamazole for a short period (in combination with levothyroxine).
|
|
|
|
 |
|